11/26
06:43 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/26
06:43 am
beam
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
11/24
09:55 am
beam
Rating for BEAM
Low
Report
Rating for BEAM
11/24
09:07 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
09:07 am
beam
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
11/24
08:11 am
beam
Beam Therapeutics initiated with an Outperform at Evercore ISI
Medium
Report
Beam Therapeutics initiated with an Outperform at Evercore ISI
11/24
08:11 am
beam
Beam Therapeutics initiated with an Outperform at Evercore ISI
Medium
Report
Beam Therapeutics initiated with an Outperform at Evercore ISI
11/17
11:03 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
11/17
11:03 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "speculative buy" rating reaffirmed by analysts at Benchmark Co..
10/10
08:06 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Medium
Report
Beam Therapeutics (NASDAQ:BEAM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
10/9
11:43 am
beam
Beam Therapeutics initiated with a Buy at Jefferies
Low
Report
Beam Therapeutics initiated with a Buy at Jefferies
10/9
11:43 am
beam
Beam Therapeutics initiated with a Buy at Jefferies
Low
Report
Beam Therapeutics initiated with a Buy at Jefferies
9/15
08:06 am
beam
Beam Therapeutics (NASDAQ:BEAM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Low
Report
Beam Therapeutics (NASDAQ:BEAM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.